https://es.marketscreener.com/cotizacion/accion/CANBRIDGE-PHARMACEUTICALS-130070920/noticia/CANbridge-Pharmaceuticals-Inc-Anuncia-la-dosificaci-n-del-primer-paciente-en-el-estudio-de-fase-2-40991952/?utm_source=telegram&utm_medium=social&utm_campaign=share